//
Readmission and Mortality After Hospitalization for Myocardial Infarction and Heart Failure
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions
Cardiovascular biomarkers in patients with acute decompensated heart failure randomized to sacubitril-valsartan or enalapril in the PIONEER-HF trial
Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial
Outcomes and Effect of Treatment According to Etiology in HFrEF An Analysis of PARADIGM-HF
Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
Angiotensin–neprilysin inhibition versus enalapril in heart failure
Diagnosis of Nonischemic Stage B Heart Failure in Type 2 Diabetes Mellitus: Optimal Parameters for Prediction of Heart Failure